ORLANDO, Fla., May 1, 2008 (PRIME NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, Inc. today announced that it has issued a fourth quarter 2007 research update on Pressure BioSciences, Inc. (Nasdaq:PBIO), a life sciences company focusing exclusively on the development and commercialization of pressure cycling technology (PCT), which has multiple applications, including genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions (particularly enzymes), immunodiagnostics, protein purification, and food safety.
Suman Preet Kaur, MBS, RedChip Research Analyst wrote in the report:
"PBIO reported more than a threefold increase in revenues in 4Q07 compared with 4Q06, as a result of the Company's strong commercialization strategy with an expanded sales force and efficient research and development staff.
"The recent introductions of Proteosolve-LRS and new ProteoSolve-SB kits highlight the growing number of demonstrated applications for the PCT technology in specific disease diagnosis and analysis. As the number of reported applications continues to grow, we believe the adaptation of PCT technology will accelerate and the market will begin to recognize the profit potential inherent in the Company," Ms. Kaur continued.
"We are reiterating our 'Speculative Buy' rating on PBIO stock and our 12-month price target of $10.00 per share given the Company's superior technology coupled with the introduction of consumables kits, which, in our belief, will accelerate sales in 2008," she concluded.
To receive a complimentary copy of the RedChip Visibility Initial Research Report for PBIO, please visit:
http://www.redchip.com/visibility/about.asp?page=vreport&reportid=101&from=05012008pr
About RedChip Companies, Inc.
RedChip Companies is an international, small-cap research and financial public relations firm with offices in Maitland, Florida; Bangalore, India; and Beijing, with affiliates in New York and San Diego. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(tm), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Internet TV(tm), and RedChip Radio(tm). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp.
"Discovering Tomorrow's Blue Chips Today"(tm)
The RedChip Companies Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=2761
Disclosure
None of the profiles issued by RedChip Companies, Inc. constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. Any investor should determine whether a particular security is suitable based on the investor's objectives, other securities holdings, financial situation needs, and tax status. Pressure BioSciences, Inc. paid RedChip Visibility, a division of RedChip Companies, Inc., $28,000 for RedChip Visibility Program services, which included the preparation of this equity research report. To the fullest extent permissible under applicable law, RedChip Companies, Inc., will not be liable to you or anyone else for the quality, accuracy, completeness, reliability, or timeliness of this information.